Table of Contents Author Guidelines Submit a Manuscript
Bioinorganic Chemistry and Applications
Volume 2010 (2010), Article ID 294169, 8 pages
http://dx.doi.org/10.1155/2010/294169
Research Article

The 33-35 Mutant -Domain Containing -Domain-Like Cluster Exhibits the Function of -Domain with Cluster in Human Growth Inhibitory Factor

1Institute of Biomedical Science, Fudan University, 220 Handan Road, Shanghai 200433, China
2Department of Chemistry, Fudan University, Shanghai 200433, China

Received 30 December 2009; Accepted 4 March 2010

Academic Editor: Spyros Perlepes

Copyright © 2010 Qingui Bao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Selkoe, “The molecular pathology of Alzheimer's disease,” Neuron, vol. 6, no. 4, pp. 487–498, 1991. View at Publisher · View at Google Scholar · View at Scopus
  2. S. H. Appel, “A unifying hypothesis for the cause of amyotrophic lateral sclerosis, Parkinsonism, and Alzheimer disease,” Annals of Neurology, vol. 10, no. 6, pp. 499–505, 1981. View at Google Scholar · View at Scopus
  3. Y. Uchida, Y. Ihara, and M. Tomonaga, “Alzheimer's disease brain extract stimulates the survival of cerebral cortical neurons from neonatal rats,” Biochemical and Biophysical Research Communications, vol. 150, no. 3, pp. 1263–1267, 1988. View at Google Scholar · View at Scopus
  4. Y. Uchida and M. Tomonaga, “Neurotrophic action of Alzheimer's disease brain extract is due to the loss of inhibitory factors for survival and neurite formation of cerebral cortical neurons,” Brain Research, vol. 481, no. 1, pp. 190–193, 1989. View at Google Scholar · View at Scopus
  5. Y. Uchida, “Growth-inhibitory factor, metallothionein-like protein, and neurodegenerative diseases,” Biological Signals, vol. 3, no. 4, pp. 211–215, 1994. View at Google Scholar · View at Scopus
  6. Y. Uchida, K. Takio, K. Titani, Y. Ihara, and M. Tomonaga, “The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein,” Neuron, vol. 7, no. 2, pp. 337–347, 1991. View at Publisher · View at Google Scholar · View at Scopus
  7. P. A. Binz and J. H. R. Kagi , “Metallothionein: molecular evolution and classification,” in Metallothionein IV, C. Klaassen, Ed., pp. 7–13, Birkhäuser, Basel, Switzerland, 1999. View at Google Scholar
  8. D. H. Hamer, “Metallothionein,” Annual Review of Biochemistry, vol. 55, pp. 913–951, 1986. View at Google Scholar
  9. R. D. Palmiter, “Molecular biology of metallothionein gene expression,” Experientia. Supplementum, vol. 52, pp. 63–80, 1987. View at Google Scholar
  10. D. R. Winge and K. A. Miklossy, “Domain nature of metallothionein,” Journal of Biological Chemistry, vol. 257, no. 7, pp. 3471–3476, 1982. View at Google Scholar · View at Scopus
  11. S. K. Krezoski, J. Villalobos, C. F. Shaw III, and D. H. Petering, “Kinetic lability of zinc bound to metallothionein in Ehrlich cells,” Biochemical Journal, vol. 255, no. 2, pp. 483–491, 1988. View at Google Scholar
  12. D. G. Nettesheim, H. R. Engeseth, and J. D. Otvos, “Products of metal exchange reactions of metallothionein,” Biochemistry, vol. 24, no. 24, pp. 6744–6751, 1985. View at Google Scholar · View at Scopus
  13. M. J. Stillman, W. Cai, and A. J. Zelazowski, “Cadmium binding to metallothioneins. Domain specificity in reactions of α and β fragments, apometallothionein, and zinc metallothionein with Cd2+,” Journal of Biological Chemistry, vol. 262, no. 10, pp. 4538–4548, 1987. View at Google Scholar · View at Scopus
  14. J. H. R. Kägi and A. Schäffer, “Biochemistry of metallothionein,” Biochemistry, vol. 27, no. 23, pp. 8509–8515, 1988. View at Google Scholar · View at Scopus
  15. C. Jacob, W. Maret, and B. L. Vallee, “Control of zinc transfer between thionein, metallothionein, and zinc proteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 7, pp. 3489–3494, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Tsuji, H. Kobayashi, Y. Uchida, Y. Ihara, and T. Miyatake, “Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease,” EMBO Journal, vol. 11, no. 13, pp. 4843–4850, 1992. View at Google Scholar · View at Scopus
  17. A. K. Sewell, L. T. Jensen, J. C. Erickson, R. D. Palmiter, and D. R. Winge, “Bioactivity of metallothionein-3 correlates with its novel β domain sequence rather than metal binding properties,” Biochemistry, vol. 34, no. 14, pp. 4740–4747, 1995. View at Google Scholar · View at Scopus
  18. Y. Uchida and Y. Ihara, “The N-terminal portion of growth inhibitory factor is sufficient for biological activity,” Journal of Biological Chemistry, vol. 270, no. 7, pp. 3365–3369, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Faller and M. Vašák, “Distinct metal-thiolate clusters in the N-terminal domain of neuronal growth inhibitory factor,” Biochemistry, vol. 36, no. 43, pp. 13341–13348, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. D. W. Hasler, L. T. Jensen, O. Zerbe, D. R. Winge, and M. Vašák, “Effect of the two conserved prolines of human growth inhibitory factor (metallothionein-3) on its biological activity and structure fluctuation: comparison with a mutant protein,” Biochemistry, vol. 39, no. 47, pp. 14567–14575, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. F.-Y. Ni, B. Cai, Z.-C. Ding et al., “Structural prediction of the ß-domain of metallothionein-3 by molecular dynamics simulation,” Proteins: Structure, Function and Genetics, vol. 68, no. 1, pp. 255–266, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. P. Williamson, “The structure and function of proline-rich regions in proteins,” Biochemical Journal, vol. 297, no. 2, pp. 249–260, 1994. View at Google Scholar · View at Scopus
  23. B. Cai, Q. Zheng, X.-C. Teng et al., “The role of Thr5 in human neuron growth inhibitory factor,” Journal of Biological Inorganic Chemistry, vol. 11, no. 4, pp. 476–482, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. W.-H. Yu, B. Cai, Y. Gao, D. Chen, and Z.-X. Huang, “Effect of mutation of Cys33 and Cys34 in the α-domain of monkey metallothionein-1 on the protein stability,” Chemical Journal of Chinese Universities, vol. 24, no. 4, pp. 569–575, 2003. View at Google Scholar
  25. R. Higuchi, B. Krummel, and R. K. Saiki, “A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions,” Nucleic Acids Research, vol. 16, no. 15, pp. 7351–7367, 1988. View at Google Scholar · View at Scopus
  26. M. Vašák, “Metal removal and substitution in vertebrate and invertebrate metallothioneins,” Methods in Enzymology, vol. 205, pp. 452–458, 1991. View at Google Scholar · View at Scopus
  27. D. R. Grassetti and J. F. Murray Jr., “Determination of sulfhydryl groups with 2,2- or 4,4-dithiodipyridine,” Archives of Biochemistry and Biophysics, vol. 119, pp. 41–49, 1967. View at Google Scholar · View at Scopus
  28. T. Y. Li, A. J. Kraker, C. F. Shaw III, and D. H. Petering, “Ligand substitution reactions of metallothioneins with EDTA and apo-carbonic anhydrase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 77, no. 11, pp. 6334–6338, 1980. View at Google Scholar · View at Scopus
  29. C. F. Shaw III, M. M. Savas, and D. H. Petering, “Ligand substitution and sulfhydryl reactivity of metallothionein,” Methods in Enzymology, vol. 205, pp. 401–414, 1991. View at Google Scholar · View at Scopus
  30. R. S. Chung, J. C. Vickers, M. I. Chuah, B. L. Eckhardt, and A. K. West, “Metallothionein-III inhibits initial neurite formation in developing neurons as well as postinjury, regenerative neurite sprouting,” Experimental Neurology, vol. 178, no. 1, pp. 1–12, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. J. C. Erickson, A. K. Sewell, L. T. Jensen, D. R. Winge, and R. D. Palmiter, “Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF),” Brain Research, vol. 649, no. 1-2, pp. 297–304, 1994. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Vašák, “Application of 113Cd NMR to metallothioneins,” Biodegradation, vol. 9, no. 6, pp. 501–512, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Öz, D. L. Pountney, and I. M. Armitage, “NMR spectroscopic studies of I=1/2 metal ions in biological systems,” Biochemistry and Cell Biology, vol. 76, no. 2-3, pp. 223–234, 1998. View at Google Scholar · View at Scopus
  34. N. Romero-Isart, L. T. Jensen, O. Zerbe, D. R. Winge, and M. Vašák, “Engineering of metallothionein-3 neuroinhibitory activity into the inactive isoform metallothionein-1,” Journal of Biological Chemistry, vol. 277, no. 40, pp. 37023–37028, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. Z.-C. Ding, X.-C. Teng, B. Cai et al., “Mutation at Glu23 eliminates the neuron growth inhibitory activity of human metallothionein-3,” Biochemical and Biophysical Research Communications, vol. 349, no. 2, pp. 674–682, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Vašák, J. H. R. Kägi, and H. A. O. Hill, “Zinc(II), cadmium(II), and mercury(II) thiolate transitions in metallothionein,” Biochemistry, vol. 20, no. 10, pp. 2852–2856, 1981. View at Google Scholar · View at Scopus
  37. Z.-C. Ding, Q. Zheng, B. Cai et al., “Effect of a-domain substitution on the structure, property and function of human neuronal growth inhibitory factor,” Journal of Biological Inorganic Chemistry, vol. 12, no. 8, pp. 1173–1179, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. L.-J. Jiang, M. Vašák, B. L. Vallee, and W. Maret, “Zinc transfer potentials of the α- and β-clusters of metallothionein are affected by domain interactions in the whole molecule,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 6, pp. 2503–2508, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Faller, D. W. Hasler, O. Zerbe, S. Klauser, D. R. Winge, and M. Vašák, “Evidence for a dynamic structure of human neuronal growth inhibitory factor and for major rearrangements of its metal-thiolate clusters,” Biochemistry, vol. 38, no. 31, pp. 10158–10167, 1999. View at Publisher · View at Google Scholar · View at Scopus